Cargando…
Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant
Transdermal drug delivery of lidocaine is a good choice for local anesthetic delivery. Microemulsions have shown great effectiveness for the transdermal transport of lidocaine. Oil-in-water nanoemulsions are particularly suitable for encapsulation of lipophilic molecules because of their ability to...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125457/ https://www.ncbi.nlm.nih.gov/pubmed/33925764 http://dx.doi.org/10.3390/molecules26092556 |
_version_ | 1783693508020797440 |
---|---|
author | Sarheed, Omar Dibi, Manar Ramesh, Kanteti V. R. N. S. Drechsler, Markus |
author_facet | Sarheed, Omar Dibi, Manar Ramesh, Kanteti V. R. N. S. Drechsler, Markus |
author_sort | Sarheed, Omar |
collection | PubMed |
description | Transdermal drug delivery of lidocaine is a good choice for local anesthetic delivery. Microemulsions have shown great effectiveness for the transdermal transport of lidocaine. Oil-in-water nanoemulsions are particularly suitable for encapsulation of lipophilic molecules because of their ability to form stable and transparent delivery systems with good skin permeation. However, fabrication of nanoemulsions containing lidocaine to provide an extended local anesthetic effect is challenging. Hence, the aim of this study was to address this issue by employing alginate-based o/w nanocarriers using nanoemulsion template that is prepared by combined approaches of ultrasound and phase inversion temperature (PIT). In this study, the influence of system composition such as oil type, oil and surfactant concentration on the particle size, in vitro release and skin permeation of lidocaine nanoemulsions was investigated. Structural characterization of lidocaine nanoemulsions as a function of water dilution was done using DSC. Nanoemulsions with small droplet diameters (d < 150 nm) were obtained as demonstrated by dynamic light scattering (DLS) and cryo-TEM. These nanoemulsions were also able to release 90% of their content within 24-h through PDMS and pig skin and able to the drug release over a 48-h. This extended-release profile is highly favorable in transdermal drug delivery and shows the great potential of this nanoemulsion as delivery system. |
format | Online Article Text |
id | pubmed-8125457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81254572021-05-17 Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant Sarheed, Omar Dibi, Manar Ramesh, Kanteti V. R. N. S. Drechsler, Markus Molecules Article Transdermal drug delivery of lidocaine is a good choice for local anesthetic delivery. Microemulsions have shown great effectiveness for the transdermal transport of lidocaine. Oil-in-water nanoemulsions are particularly suitable for encapsulation of lipophilic molecules because of their ability to form stable and transparent delivery systems with good skin permeation. However, fabrication of nanoemulsions containing lidocaine to provide an extended local anesthetic effect is challenging. Hence, the aim of this study was to address this issue by employing alginate-based o/w nanocarriers using nanoemulsion template that is prepared by combined approaches of ultrasound and phase inversion temperature (PIT). In this study, the influence of system composition such as oil type, oil and surfactant concentration on the particle size, in vitro release and skin permeation of lidocaine nanoemulsions was investigated. Structural characterization of lidocaine nanoemulsions as a function of water dilution was done using DSC. Nanoemulsions with small droplet diameters (d < 150 nm) were obtained as demonstrated by dynamic light scattering (DLS) and cryo-TEM. These nanoemulsions were also able to release 90% of their content within 24-h through PDMS and pig skin and able to the drug release over a 48-h. This extended-release profile is highly favorable in transdermal drug delivery and shows the great potential of this nanoemulsion as delivery system. MDPI 2021-04-27 /pmc/articles/PMC8125457/ /pubmed/33925764 http://dx.doi.org/10.3390/molecules26092556 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sarheed, Omar Dibi, Manar Ramesh, Kanteti V. R. N. S. Drechsler, Markus Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant |
title | Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant |
title_full | Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant |
title_fullStr | Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant |
title_full_unstemmed | Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant |
title_short | Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant |
title_sort | fabrication of alginate-based o/w nanoemulsions for transdermal drug delivery of lidocaine: influence of the oil phase and surfactant |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125457/ https://www.ncbi.nlm.nih.gov/pubmed/33925764 http://dx.doi.org/10.3390/molecules26092556 |
work_keys_str_mv | AT sarheedomar fabricationofalginatebasedownanoemulsionsfortransdermaldrugdeliveryoflidocaineinfluenceoftheoilphaseandsurfactant AT dibimanar fabricationofalginatebasedownanoemulsionsfortransdermaldrugdeliveryoflidocaineinfluenceoftheoilphaseandsurfactant AT rameshkantetivrns fabricationofalginatebasedownanoemulsionsfortransdermaldrugdeliveryoflidocaineinfluenceoftheoilphaseandsurfactant AT drechslermarkus fabricationofalginatebasedownanoemulsionsfortransdermaldrugdeliveryoflidocaineinfluenceoftheoilphaseandsurfactant |